RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Long Term Care
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Residents
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
>
Therapeutic Categories
>
Urogenital System
> Overactive bladder/enuresis
Urogenital System
»
Overactive bladder/enuresis
Select All |
Compare
|
Add to Clipboard
|
View Clipboard
Name
Compare
DDAVP
compare
DETROL
compare
DETROL LA
compare
DITROPAN
compare
DITROPAN SYRUP
compare
DITROPAN XL
compare
ENABLEX
compare
GELNIQUE
compare
SANCTURA
compare
SANCTURA XR
compare
TOFRANIL
compare
TOVIAZ
compare
VESICARE
compare
Most Popular
Most Emailed
Most Recent
Hizentra approved for primary immunodeficiency
Xiaflex available for Dupuytren's contracture
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphophonates
Pediaderm HC Complete Kit available for atopic dermatitis
Botox approved for upper limb spasticity
Generic timolol maleate ophthalmic gel forming solution available
New Product: SAPHRIS
®
(asenapine) Sublingual Tablets
FDA warns of intravascular hemolysis risk with WinRho SDF
FDA accepts NDA for lurasidone, a treatment for schizophrenia
Trelstar 22.5mg approved for palliative treatment of prostate cancer
Recommended Adult Immunization Schedule
Prevnar 13 pneumococcal disease vaccine approved
Hizentra approved for primary immunodeficiency
Kapidex to be marketed under new trade name Dexilant
FDA grants priority review to Tasigna for newly diagnosed chronic myeloid leukemia
FDA accepts NDA for JZP-6, a treatment for fibromyalgia
Rituxan approved for chronic lymphocytic leukemia
Victoza available for type 2 diabetes
Generic tamsulosin available for benign prostatic hyperplasia (BPH)
Exalgo approved for moderate to severe pain
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphophonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
FDA accepts NDA for lurasidone, a treatment for schizophrenia
FDA warns of intravascular hemolysis risk with WinRho SDF
Botox approved for upper limb spasticity
New Product: SAPHRIS
®
(asenapine) Sublingual Tablets
Pediaderm HC Complete Kit available for atopic dermatitis
Generic timolol maleate ophthalmic gel forming solution available
Xiaflex available for Dupuytren's contracture
Hizentra approved for primary immunodeficiency
Sponsored Links